DeepMed Research

Azienda Ospedaliero-Universitaria di Parma

🇮🇹Italy

Country: 🇮🇹Italy

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.ao.pr.it

Clinical Trials

Indications and Outcomes in Kidney-ureteral Pediatric Lithiasis: Experience of Parma

Completed

Conditions: Pediatric ALL
Stone, Urinary

First Posted Date: 2020-10-28

Last Posted Date: 2020-10-30

Lead Sponsor: Azienda Ospedaliero-Universitaria di Parma

Target Recruit Count: 70

Registration Number: NCT04605315

Locations: 🇮🇹
AOU Parma, Parma, Italy

Clinical Phenotype and Outcomes of Inpatients With COVID-19 and Diabetes

Completed

Conditions: Covid19
Diabetes Mellitus

First Posted Date: 2020-09-16

Last Posted Date: 2022-02-17

Lead Sponsor: Azienda Ospedaliero-Universitaria di Parma

Target Recruit Count: 757

Registration Number: NCT04550403

Locations: 🇮🇹
Endocrinology and metabolic diseases Unit, Parma, Italy

Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19

Phase 2

Withdrawn

Conditions: Covid-19
Corona Virus Infection
SARS-CoV 2

Interventions: Drug: Standard of Care
Drug: Oxytocin

First Posted Date: 2020-05-13

Last Posted Date: 2021-01-14

Lead Sponsor: Azienda Ospedaliero-Universitaria di Parma

Registration Number: NCT04386447

Locations: 🇮🇹
Ospedale San Francesco, Nuoro, Italy
🇮🇹
Azienda Ospedaliero Universitaria di Parma, Parma, PR, Italy
🇫🇷
CNRS, Lyon, France

Colchicine Counteracting Inflammation in COVID-19 Pneumonia

Phase 2

Completed

Conditions: Pneumonia, Viral
Coronavirus Infections

Interventions: Drug: Colchicine

First Posted Date: 2020-03-26

Last Posted Date: 2022-07-20

Lead Sponsor: Azienda Ospedaliero-Universitaria di Parma

Target Recruit Count: 193

Registration Number: NCT04322565

Locations: 🇮🇹
Azienda Ospedaliero Universitaria di Parma, Parma, PR, Italy

Italian Multicenter Database for Open Conversions After EVAR

Not yet recruiting

Conditions: Abdominal Aortic Aneurysm Enlargement
Abdominal Aortic Aneurysm

Interventions: Procedure: Open Conversion after EVAR
Procedure: SemiConversion after EVAR

First Posted Date: 2020-03-09

Last Posted Date: 2020-07-09

Lead Sponsor: Azienda Ospedaliero-Universitaria di Parma

Target Recruit Count: 500

Registration Number: NCT04299984

Managing DIabetes Remission After Combined Therapy in EarLy Stage of DiabetEs

Phase 3

Completed

Conditions: Newly Diagnosed Type 2 Diabetes

Interventions: Drug: Metformin-Sitagliptin-Empaglifozin-Pioglitazone
Drug: Standard of care

First Posted Date: 2020-02-17

Last Posted Date: 2025-03-18

Lead Sponsor: Azienda Ospedaliero-Universitaria di Parma

Target Recruit Count: 108

Registration Number: NCT04271189

Locations: 🇮🇹
Azienda Ospedaliero Universitaria di Parma, Parma, Italy

Lung Elastrosonography in Diagnosis and Stratification of COPD and Fibrosis

Not Applicable

Completed

Conditions: Chronic Obstructive Pulmonary Disease
Smoker Lung

Interventions: Diagnostic Test: Lung Elastosonography

First Posted Date: 2019-11-04

Last Posted Date: 2021-01-13

Lead Sponsor: Azienda Ospedaliero-Universitaria di Parma

Target Recruit Count: 66

Registration Number: NCT04149652

Locations: 🇮🇹
UO Medicina Interna e Lungodegenza Critica, Azienda Ospedaliero-Universitaria di Parma, Parma, Emilia-Romagna, Italy

Multidisciplinary Mobile Unit for Preventing Hospitalization of Nursing Home Residents

Terminated

Conditions: Respiratory Failure
Frailty
Abdominal Pain
Infection
Disability
Multimorbidity

Interventions: Other: Multidisciplinary Mobile Unit (MMU)

First Posted Date: 2019-09-11

Last Posted Date: 2021-01-14

Lead Sponsor: Azienda Ospedaliero-Universitaria di Parma

Target Recruit Count: 13

Registration Number: NCT04085679

Locations: 🇮🇹
UO Medicina Interna e Lungodegenza Critica, Azienda Ospedaliero-Universitaria di Parma, Parma, Emilia-Romagna, Italy

Feasibility and Safety of "Flash Glucose Monitoring-FGM" in an Adult Italian Population.

Completed

Conditions: Diabetes Mellitus, Type 1

Interventions: Device: Flash Glucose Monitoring-FGM

First Posted Date: 2019-08-19

Last Posted Date: 2021-01-13

Lead Sponsor: Azienda Ospedaliero-Universitaria di Parma

Target Recruit Count: 350

Registration Number: NCT04060732

Locations: 🇮🇹
Azienda Ospedaliero Universitaria, Parma, Italy

Pharmacogenetics of Clopidogrel in Acute Coronary Syndromes

Not Applicable

Terminated

Conditions: Acute Coronary Syndromes

Interventions: Other: clinical algorithm
Genetic: genetic tests for CYP2C19*2, CYP2C19*17 and ABCB1 3435

First Posted Date: 2017-11-20

Last Posted Date: 2017-11-20

Lead Sponsor: Azienda Ospedaliero-Universitaria di Parma

Target Recruit Count: 889

Registration Number: NCT03347435

Locations: 🇮🇹
Ospedale Ramazzini, Carpi, Modena, Italy
🇮🇹
Azienda Ospedaliero Universitaria di Parma, Parma, Italy
🇮🇹
Ospedale di Vaio, Fidenza, Parma, Italy

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy